Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey*.

MLA

Mahil, S. K., et al. “Risk‐mitigating Behaviours in People with Inflammatory Skin and Joint Disease during the COVID‐19 Pandemic Differ by Treatment Type: A Cross‐sectional Patient Survey*.” British Journal of Dermatology, vol. 185, no. 1, July 2021, pp. 80–90. EBSCOhost, https://doi.org/10.1111/bjd.19755.

APA

Mahil, S. K., Yates, M., Langan, S. M., Yiu, Z. Z. N., Tsakok, T., Dand, N., Mason, K. J., McAteer, H., Meynell, F., Coker, B., Vincent, A., Urmston, D., Vesty, A., Kelly, J., Lancelot, C., Moorhead, L., Bachelez, H., Bruce, I. N., Capon, F., & Contreras, C. R. (2021). Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey*. British Journal of Dermatology, 185(1), 80–90. https://doi.org/10.1111/bjd.19755

Chicago

Mahil, S.K., M. Yates, S.M. Langan, Z.Z.N. Yiu, T. Tsakok, N. Dand, K.J. Mason, et al. 2021. “Risk‐mitigating Behaviours in People with Inflammatory Skin and Joint Disease during the COVID‐19 Pandemic Differ by Treatment Type: A Cross‐sectional Patient Survey*.” British Journal of Dermatology 185 (1): 80–90. doi:10.1111/bjd.19755.